Products

InferRead Lung CT.AI
Infervision Medical Technology Co.
Oncology AI
InferRead Lung CT.AI by Infervision is an AI-powered tool designed to assist radiologists in detecting, quantifying, and classifying pulmonary nodules from chest CT scans, enhancing diagnostic accuracy and efficiency for lung cancer screening and diagnosis.
InferRead CT Stroke.AI
Infervision Medical Technology Co.
Neurology AI
InferRead CT Stroke.AI is an AI-powered software by Infervision Medical Technology Co. designed to prioritize head CT scans by flagging suspected intracranial hemorrhage (ICH) cases, aiding radiologists in faster triage and improved workflow efficiency.

See all 2 products →

About Infervision Medical Technology

Infervision Medical Technology is a leading AI medical technology company established in 2016, dedicated to enhancing multi-disciplinary healthcare services through artificial intelligence. The company offers a comprehensive suite of AI-assisted software solutions designed to support physicians across the entire clinical workflow: from disease screening and diagnosis to patient treatment and management, and even research and development.

Their advanced platforms leverage deep learning technologies to analyze medical imaging data from various modalities, including DR, CT, and MRI. These solutions aim to improve diagnostic accuracy and efficiency for a wide array of conditions, such as various cancers, infectious diseases (e.g., tuberculosis, pneumonia, including COVID-19), cardiovascular diseases, cerebrovascular diseases (like strokes and intracranial hemorrhages), and trauma. Key product lines include InferRead® for diagnostic assistance, InferOperate® for surgical planning and intervention, InferCare® for patient health management, and InferScholar®/InferMartrix for medical research. Infervision’s products have received significant regulatory clearances, including FDA, CE, PMDA, UKCA, and NMPA, facilitating their adoption in major global markets.

Focus Areas

AI-based medical imaging clinical diagnosis solutions disease screening disease diagnosis patient treatment and management medical research and development oncology pulmonary disease cardiovascular diseases cerebrovascular diseases trauma stroke detection lung cancer screening tuberculosis detection COVID-19 assessment surgical planning 3D reconstruction

Business Intelligence

Key InvestorsCDH, Qiming Venture Partners, CCB Trust, Sequoia Capital, Goldman Sachs Asset Management, Z-Park Fund, Springhill Fund, Advantech Capital, Genesis Capital, Xianghe Capital Co.
PartnershipsSimonMed, Viz.ai, GE Healthcare (in China), NHS SBS framework, Peking Union Medical College Hospital, Shanghai Changzheng Hospital, Tongji Medical College of HUST in Wuhan, Dalian Zhongshan Hospital, Beijing Tian Tan Hospital, Pärnu Hospital, Hospital Vall d'Hebron, NVIDIA
TechnologyDeep learning technology, neural network-based medical imaging, computer vision, AI application management platform, AI data-mining research platform, AI clinical application platforms, InferMatrix (AI-enabled medical application platform), cloud-based and on-premise deployment options, NVIDIA's MONAI framework, NVIDIA's TensorRT-accelerated inference, Convolutional Neural Network (CNN)
FDA Clearances4 cleared products (estimated)

What Physicians Need to Know

AI-based Medical Imaging & Diagnosis
Infervision offers the InferReadu00ae suite, providing AI-assisted diagnosis across various modalities (DR, CT, MRI) for comprehensive body areas including chest, brain, bone, and heart. This includes solutions for pulmonary nodules, pneumonia, intracranial hemorrhage, coronary artery disease, and chest fractures.
Disease Screening & Early Detection
Specializes in early detection and screening programs, such as InferRead Lung CT.AI for lung cancer screening, InferRead DR Chest for tuberculosis, InferRead CT Pneumonia for COVID-119 assessment, and InferRead CT Stroke for rapid stroke detection.
Patient Treatment & Management
The InferOperateu00ae Suite provides advanced tools for surgical planning, including high-precision, fully automated 3D reconstructions for thorax, liver, and urology, supporting preoperative planning and intraoperative visualization. InferCareu00ae also supports patient health management.
Medical Research & Development
InferScholaru00ae and InferMatrix are AI-enabled platforms designed to empower medical research, allowing physicians with limited coding experience to conduct deep-learning analytical research and integrate algorithms into user-friendly applications.
Oncology Solutions
Provides critical support for oncology, particularly in lung cancer screening and nodule detection, aiding radiologists, surgeons, and oncologists in making informed decisions for earlier diagnosis and improved patient outcomes.
Cardiovascular & Cerebrovascular Health
Offers AI solutions for coronary artery disease (InferRead CT Coronary) to evaluate stenosis, and for cerebrovascular diseases like stroke (InferRead CT Stroke) for rapid detection of hemorrhagic and ischemic strokes, including innovative 5G mobile stroke units.
Key Differentiators
Infervision stands out with its comprehensive AI platforms, multi-modality support (DR, CT, MRI), and global certifications (US FDA, European CE, Japan PMDA, UK UKCA, China NMPA). Their solutions are designed for seamless clinical integration, workflow efficiency, high accuracy, and sensitivity, even to subtle anomalies. The company is highly research-driven, with a significant R&D team and numerous academic publications, offering both local and cloud-based deployment options.
Technology Stack
The core of Infervision's technology stack includes advanced Artificial Intelligence and Deep Learning algorithms, specifically Convolutional Neural Networks (CNNs), combined with computer vision techniques. They also leverage 5G technology in specialized applications like their mobile stroke unit.
Physician Tip

Infervision's AI solutions are designed to significantly improve diagnostic accuracy and efficiency by detecting subtle anomalies and reducing missed diagnoses, thereby leading to earlier interventions and better patient outcomes, especially in time-sensitive conditions like stroke and lung cancer. Physicians benefit from comprehensive clinical support spanning screening, diagnosis, treatment planning, and follow-up, with quantitative and standardized reporting that includes detailed analytical information and comparisons with prior studies. The automation of routine tasks and highlighting of critical findings help reduce workload and burnout, allowing physicians to focus on complex cases and patient care. Furthermore, their platforms facilitate multi-specialty collaboration and empower physicians to engage in deep-learning analytical research, even with limited coding experience.

Infervision's solutions are built for seamless integration into existing medical workflows and Picture Archiving and Communication Systems (PACS). They have established strategic partnerships for integration with leading platforms such as ConcertAI's TeraRecon Eureka Clinical AI and the Viz.ai ecosystem, ensuring their AI capabilities can be easily incorporated into diverse healthcare environments.

Products by Infervision Medical Technology

2 products in the directory

InferRead Lung CT.AI
Infervision Medical Technology Co.
Oncology AI
InferRead Lung CT.AI by Infervision is an AI-powered tool designed to assist radiologists in detecting, quantifying, and classifying pulmonary nodules from chest CT scans, enhancing diagnostic accuracy and efficiency for lung cancer screening and diagnosis.
InferRead CT Stroke.AI
Infervision Medical Technology Co.
Neurology AI
InferRead CT Stroke.AI is an AI-powered software by Infervision Medical Technology Co. designed to prioritize head CT scans by flagging suspected intracranial hemorrhage (ICH) cases, aiding radiologists in faster triage and improved workflow efficiency.

What the Web Says

Infervision Medical Technology is an AI medical technology company founded in 2016, specializing in AI-driven platforms and tools for disease screening, diagnosis, intervention, treatment, patient management, and medical research. Their products, such as InferRead Lung CT.AI, have received FDA clearance and CE mark, and are used in over 380 hospitals globally, processing over 55,000 cases daily. The company emphasizes speed, workflow friendliness, and accuracy in its product development.

Overall: Positive

Strengths

  • AI-driven platforms aid in quick and accurate diagnosis and treatment of diseases.
  • Products like InferRead Lung CT.AI can improve diagnostic accuracy and reduce reading times for radiologists.
  • Technology can identify early signs of disease and detect abnormalities that traditional methods might miss.
  • Solutions are designed to be user-friendly and integrate into existing medical workflows.
  • Infervision's AI has shown success in detecting early signs of lung cancer and diagnosing strokes more quickly and accurately.
  • The company's products have received international regulatory clearances (FDA, CE, UKCA), expanding global accessibility.

Limitations

  • No specific cons were found in the provided search results regarding Infervision Medical Technology's products or employer reviews from the requested sources (G2, Glassdoor, Capterra, Reddit, healthcare IT reviewers).
  • Some search results for similarly named companies (Innervision, Infovision, Invision Health, InfoCision) showed mixed or negative employee reviews regarding work-life balance, pay, management, and job security, but these are not directly related to Infervision Medical Technology.

Based on reviews from: G2, Forbes, SourceForge, AITopTools, News Center, Slashdot

Last updated: 2026-07-18

Videos

News, demos, and interviews about Infervision Medical Technology.

Loading videos...

Videos load interactively. If none appear, search YouTube for Infervision Medical Technology →

View all on YouTube

Press & Coverage

Infervision
Infervision Receives FDA 510(k) Clearance for Enhanced Features in InferRead CT Lung
Infervision's InferReadu00ae Lung CT.AI received FDA 510(k) clearance for enhanced features, including detection of nodules as small as 4mm and expanded structured assessments, strengthening its position in AI-driven lung nodule detection.
2025-05
Infervision
Infervision Receives FDA Clearance of InferOperate Suite
Infervision's InferOperate Suite, an AI surgical planning solution, received FDA 510(k) clearance, making it the first cleared for use in the US, EU, UK, and China.
2025-09
Infervision
Leading the Future of Medical Imaging: InferVision Showcases Global-Ready AI Innovations at RSNA 2025
InferVision showcased new breakthroughs in surgical planning, oncology assessment, and global ecosystem collaboration at RSNA 2025, highlighting its InferOperate automatic 3D reconstruction products which have achieved major regulatory milestones.
2025-12
Infervision
Infervision's AI Solutions for Chest, Brain, and Heart Secure CE and UKCA Certifications
Infervision's AI-assisted diagnostic solutions for chest, brain, and heart received dual certification from European MDR CE and UKCA, strengthening its presence in European and UK markets.
2024-08
Infervision
Viz.ai and Infervision Partner on AI Solution to Aid in Earlier Detection and Clinical Workup of Lung Cancer
Viz.ai partnered with Infervision to incorporate InferRead Lung CT.AI, Infervision's FDA-cleared AI solution for lung nodule detection, into the Viz.ai ecosystem to improve early lung cancer detection.
2024-04
Infervision (Journal of Imaging Informatics in Medicine)
Deep Learning Models of Multiu2011Scale Lesion Perception Attention Networks for Diagnosis and Staging of Pneumoconiosis: A Comparative Study with Radiologists
This peer-reviewed article discusses deep learning models for pneumoconiosis diagnosis and staging, comparing their performance with radiologists.
2024-06
PR Newswire
InferVision Completes Series D2 Financing Round Led by Goldman Sachs Asset Management
InferVision completed its Series D2 financing round, led by Goldman Sachs Asset Management, raising approximately US$140 million in total for R&D, distribution channel expansion, and business development.
2021-08
Infervision
AI-based chest CT semantic segmentation algorithm enables semi-automated lung cancer surgery planning by recognizing anatomical variants of pulmonary vessels
This research paper details an AI-based semantic segmentation algorithm for semi-automated lung cancer surgery planning, demonstrating its effectiveness in recognizing anatomical variants of pulmonary vessels.
2025-07

Frequently Asked Questions

Infervision offers a comprehensive suite of AI-assisted software under its InferReadu00ae series, including solutions for chest CT (lung nodules, pneumonia, COVID-19), DR Chest (tuberculosis, various pathologies), CT Coronary (coronary artery stenosis), CT Stroke (intracranial hemorrhage), and CT Bone (chest fractures). These tools are designed to enhance diagnostic accuracy and efficiency across various medical imaging modalities. [2, 3, 9, 13]
Infervision's InferOperateu00ae Suite provides high-precision, automated 3D anatomical segmentation for surgical planning in areas like thorax, liver, and urology, aiding in preoperative planning and intraoperative visualization. Additionally, InferCareu00ae is designed for effective patient health management and image follow-up. [2, 3, 14, 22]
Infervision's products have achieved significant global regulatory clearances, including certifications from the US FDA, European CE (MDR), UK UKCA, Japan PMDA, and China NMPA. The company also emphasizes a robust cybersecurity infrastructure for its cloud-based solutions to ensure strict data protection and patient information safeguards. [2, 14, 18, 19]
Yes, Infervision's AI solutions are designed for seamless integration into clinical workflows, supporting radiologists, surgeons, and oncologists. The company has established partnerships with entities like Viz.ai to incorporate InferRead Lung CT.AI into their ecosystem and with ConcertAI's TeraRecon for integration into the Eureka Clinical AI platform. [4, 10]
Infervision supports medical research and development through its InferScholaru00ae, InferMartrix, and InferEducate platforms. InferScholar AI, for instance, is an AI-enabled research platform that allows physicians with limited coding experience to conduct scientific research using deep-learning analytical tools. [2, 3, 7, 15]
Founded in 2016, Infervision has demonstrated strong financial stability, raising over $210 million in funding across 8 rounds, including a Series D2 led by Goldman Sachs Asset Management. The company has a significant global presence with offices in the US, Europe, UK, and Japan, and its products are used by healthcare providers in nearly 20 countries. [6, 8, 17, 19, 21]
Infervision offers specialized AI solutions for a wide range of critical diseases. This includes InferRead CT Lung for lung cancer screening and nodule detection, InferRead CT Coronary for coronary artery disease, and InferRead CT Stroke for rapid detection of intracranial hemorrhage, alongside solutions for pneumonia, tuberculosis, and trauma. [2, 3, 9]

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare fintech company that leverages AI and automation to address the growing challenge of healthcare affordability for patients and financial stability for providers. The platform offers personalized, interest-free payment plans, extending up to 60 months, tailored to each patient’s ability to pay. This approach aims to remove financial barriers to care, allowing […]

Healthcare Finance.AI is dedicated to optimizing healthcare revenue cycles through cutting-edge AI technologies. The company aims to improve financial outcomes for healthcare providers while supporting their commitment to quality care and efficiency. Their solutions are designed to enhance revenue cycle efficiency, reduce claim turnaround times, and improve patient billing accuracy. Their platform leverages advanced analytics […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School, a faculty of Imperial College London, is a leading institution that integrates business education with science, engineering, medicine, and technology. For physicians and healthcare providers, the Business School offers specialized programs and research focused on the intersection of AI, digital transformation, and healthcare management. Their curriculum is designed to equip healthcare […]

Columbia University, through its online learning platform edX, offers a range of educational programs, including those focused on artificial intelligence and its applications in healthcare. While not a direct AI product company, Columbia University provides foundational and advanced courses that equip physicians and healthcare providers with the knowledge and skills to understand, evaluate, and potentially […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.